BAWEI
837023
XI'AN WONDER
836419
Jiangsu Tiangong Technology
920068
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
CN Stock MarketDetailed Quotes
688385 Shanghai Fudan Microelectronics Group
- 45.34
- -0.40-0.87%
Market Closed May 15 15:00 CST
37.24BMarket Cap67.98P/E (TTM)
46.26High45.18Low56.34KlotVolume45.66Open45.74Pre Close257.27MTurnover1.05%Turnover Ratio65.05P/E (Static)821.43MShares54.1552wk High6.17P/B24.35BFloat Cap23.5552wk Low54.89Limit Up537.10MShs Float99.77Historical High36.59Limit Down2.36%Amplitude23.08Historical Low0.10Dividend TTM45.66Avg Price27.60KlotAsk0.22%Div YieldTTM100Lot Size25.08KlotBid
Shanghai Fudan Microelectronics Group Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -0.54%887.95M | 1.53%3.59B | -1.99%2.68B | -0.12%1.79B | 10.30%892.74M | -0.07%3.54B | 1.25%2.74B | 5.52%1.8B | 4.33%809.36M | 37.31%3.54B |
| Operating revenue | -0.54%887.95M | 1.53%3.59B | -1.99%2.68B | -0.12%1.79B | 10.30%892.74M | -0.07%3.54B | 1.25%2.74B | 5.52%1.8B | 4.33%809.36M | 37.31%3.54B |
| Total operating cost | -1.29%730.17M | 8.43%3.05B | 15.28%2.35B | 17.09%1.54B | 26.74%739.7M | 19.10%2.82B | 14.63%2.03B | 15.41%1.31B | 8.43%583.62M | 15.59%2.36B |
| Operating cost | -3.95%371.74M | 15.30%1.58B | 24.38%1.21B | 32.11%780.62M | 43.91%387.03M | 9.71%1.37B | 2.55%969.89M | -0.83%590.91M | -4.80%268.94M | 18.07%1.25B |
| Operating tax surcharges | 119.14%5.02M | 42.44%11.78M | 10.05%6.87M | 5.45%4.63M | 5.57%2.29M | -66.32%8.27M | -70.73%6.25M | -66.76%4.39M | -68.17%2.17M | 100.28%24.56M |
| Operating expense | -0.07%60M | -3.82%242.13M | -0.91%182.19M | -1.54%120.36M | 2.31%60.04M | 12.98%251.74M | 15.83%183.85M | 25.05%122.23M | 14.07%58.69M | 29.82%222.82M |
| Administration expense | 5.82%37.96M | 0.32%158.44M | 3.43%115.13M | -4.17%70.94M | 0.01%35.87M | 13.68%157.94M | 12.83%111.3M | 23.66%74.03M | 21.07%35.87M | 23.99%138.94M |
| Financial expense | -17.61%7.56M | 82.57%28.67M | 478.91%30.91M | 336.28%18.58M | 756.49%9.17M | 302.50%15.7M | 156.10%5.34M | -82.74%-7.86M | -69.53%-1.4M | -561.74%-7.75M |
| -Interest expense (Financial expense) | -8.70%9.98M | 52.62%42.71M | 86.01%32.12M | 182.27%21.46M | 719.89%10.94M | 542.66%27.99M | 480.33%17.27M | 237.05%7.6M | 23.41%1.33M | -3.82%4.35M |
| -Interest Income (Financial expense) | -9.57%-4.28M | -8.05%-16.8M | -5.60%-12.55M | 4.50%-8.15M | 18.45%-3.91M | -4.94%-15.54M | -13.20%-11.88M | -13.55%-8.53M | -78.58%-4.79M | -75.69%-14.81M |
| Research and development | 1.06%247.89M | 1.98%1.03B | 6.07%803.84M | 2.41%540.3M | 11.83%245.3M | 37.42%1.01B | 35.35%757.83M | 41.15%527.6M | 30.06%219.34M | 6.33%735.42M |
| Credit Impairment Loss | -108.15%-14.62M | -235.10%-45.68M | -14.65%-32.95M | -11.81%-15.03M | 66.19%-7.03M | -1,328.08%-13.63M | -253.75%-28.74M | -142.35%-13.44M | -419.51%-20.78M | 184.66%1.11M |
| Asset Impairment Loss | -1,208.41%-29.93M | -26.40%-168.77M | 51.02%-36.9M | 94.34%-2.95M | 123.32%2.7M | 17.99%-133.52M | 14.09%-75.33M | -24.39%-52.05M | -42.19%-11.58M | -150.93%-162.8M |
| Other net revenue | ||||||||||
| Fair value change income | -472.87%-157.95K | 115.03%210.24K | 103.10%50K | 112.68%209.36K | -80.51%42.36K | -174.95%-1.4M | -194.94%-1.61M | -258.85%-1.65M | -64.46%217.3K | 96.86%1.87M |
| Invest income | 286.79%866K | -88.55%513.79K | -108.67%-90.33K | -173.64%-951.69K | -498.79%-463.62K | 368.06%4.49M | 224.40%1.04M | 49.40%1.29M | -112.12%-77.43K | 38.30%-1.67M |
| -Including: Investment income associates | 70.42%-343.4K | -1,335.06%-3.43M | 7.41%-2.92M | 2.95%-2.02M | -17.88%-1.16M | 97.06%-239.04K | 23.46%-3.15M | 31.76%-2.08M | 29.05%-985.02K | -47.09%-8.13M |
| Asset deal income | -2,059.99%-12.08K | 71.19%2.12M | 383.87%2.45M | 150.68%925.63K | -99.85%616.57 | -7.00%1.24M | -67.28%505.59K | 8,117.86%369.25K | 30,297.78%403.38K | 156.10%1.33M |
| Other revenue | -35.56%17.2M | 34.33%233.6M | 117.48%142.13M | 120.18%103.67M | 85.50%26.69M | 62.65%173.9M | 26.23%65.36M | 94.51%47.08M | 5.96%14.39M | -1.81%106.92M |
| Operating profit | -25.07%131.12M | -25.62%558.94M | -37.86%413.09M | -26.15%344.56M | -16.00%174.99M | -32.99%751.42M | -25.21%664.79M | -14.38%466.54M | -13.30%208.31M | 95.58%1.12B |
| Add:Non operating Income | -41.30%0.54 | 7.81%467.69K | -87.51%54.2K | 12,487,929.27%51.2K | --0.92 | 289.39%433.8K | 289.68%433.8K | -100.00%0.41 | ---- | 6.12%111.4K |
| Less:Non operating expense | ---- | --513.57K | --500.04K | --500K | ---- | ---- | ---- | ---- | ---- | -98.17%300 |
| Add:Adjusted items effecting total profit | ---- | ---- | ---- | ---- | ---0.92 | ---- | ---- | ---- | ---- | ---- |
| Total profit | -25.07%131.12M | -25.66%558.89M | -37.97%412.64M | -26.24%344.11M | -16.00%174.99M | -32.96%751.85M | -25.17%665.23M | -14.38%466.54M | -13.30%208.31M | 95.57%1.12B |
| Less:Income tax cost | -85.60%2.4M | -128.92%-865.38K | 30.98%1.7M | 73.98%4.42M | 20.80%16.65M | -29.53%2.99M | -37.00%1.3M | -24.22%2.54M | 557.70%13.78M | -69.94%4.25M |
| Add:Adjusted items effecting net profit | ---- | ---- | ---- | ---- | 9,300.00%0.92 | ---- | ---- | ---- | ---0.01 | ---- |
| Net profit | -18.71%128.72M | -25.25%559.76M | -38.11%410.94M | -26.79%339.68M | -18.60%158.35M | -32.97%748.86M | -25.15%663.93M | -14.32%464M | -18.33%194.53M | 99.75%1.12B |
| Net profit from continuing operation | -18.71%128.72M | -25.25%559.76M | -38.11%410.94M | -26.79%339.68M | -18.60%158.35M | -32.97%748.86M | -25.15%663.93M | -14.32%464M | -18.33%194.53M | 99.75%1.12B |
| Less:Minority Profit | -157.06%-7.46M | -143.71%-12.84M | -218.24%-16.3M | -157.09%-8.41M | -146.27%-2.9M | -27.35%29.36M | -50.40%13.79M | 33.57%14.73M | 19.36%6.27M | -9.89%40.42M |
| Net profit of parent company owners | -15.55%136.18M | -20.42%572.6M | -34.29%427.24M | -22.52%348.09M | -14.35%161.25M | -33.18%719.49M | -24.33%650.14M | -15.32%449.27M | -19.18%188.26M | 109.31%1.08B |
| Earning per share | ||||||||||
| Basic earning per share | -15.00%0.17 | -20.45%0.7 | -35.00%0.52 | -23.64%0.42 | -13.04%0.2 | -33.33%0.88 | -23.81%0.8 | -15.38%0.55 | -20.69%0.23 | 91.30%1.32 |
| Diluted earning per share | -15.00%0.17 | -19.54%0.7 | -34.18%0.52 | -23.64%0.42 | -13.04%0.2 | -33.59%0.87 | -24.76%0.79 | -15.38%0.55 | -17.86%0.23 | 89.86%1.31 |
| Other composite income | -655.97%-174.45K | -96.41%87.46K | -113.46%-230.26K | -88.98%206.89K | 554.97%31.38K | -23.19%2.44M | -52.87%1.71M | 13.07%1.88M | 102.24%4.79K | 170.87%3.18M |
| Other composite income of parent company owners | -655.97%-174.45K | -96.41%87.46K | -113.46%-230.26K | -88.98%206.89K | 554.97%31.38K | -23.19%2.44M | -52.87%1.71M | 13.07%1.88M | 102.24%4.79K | 170.87%3.18M |
| Total composite income | -18.84%128.54M | -25.48%559.85M | -38.30%410.71M | -27.04%339.89M | -18.59%158.38M | -32.95%751.3M | -25.26%665.64M | -14.24%465.87M | -18.25%194.54M | 99.90%1.12B |
| Total composite income of parent company owners | -15.67%136M | -20.67%572.68M | -34.49%427.01M | -22.80%348.3M | -14.34%161.28M | -33.16%721.93M | -24.45%651.85M | -15.23%451.15M | -19.10%188.27M | 109.45%1.08B |
| Total composite income of minority owners | -157.06%-7.46M | -143.71%-12.84M | -218.24%-16.3M | -157.09%-8.41M | -146.27%-2.9M | -27.35%29.36M | -50.40%13.79M | 33.57%14.73M | 19.36%6.27M | -9.89%40.42M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | -- | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.